The EICESS-92 trial compared the efficacy of cyclophosphamide and ifosfamide in patients with Ewing sarcoma. Subgroup analysis suggested that patients with large, localized tumors benefited from ...

The magnitude of each of these metabolic routes varies greatly between individual patients, while the influence (if any) of ifosfamide dose and schedule on its metabolism is unclear. [54,64 ...